pharma · Ischemic Stroke · Spinal Cord Injury
Neuroscience Trials Australia
Neuroscience Trials Australia clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Parkville, AU
- Employees
- 14
- Programs
- 5
- Drugs
- 9
- Patents
- 0
Neuroscience Trials Australia projects
5 ClinicalTrials.gov programs sponsored by Neuroscience Trials Australia.
Neuroscience Trials Australia has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Direct endovascular clot retrieval
Neuroscience Trials Australia
Ischemic Stroke
1 trial -
Tissue Plasminogen Activator (Alteplase)
Neuroscience Trials Australia
Stroke
1 trial -
Bone marrow derived stem cells
Neuroscience Trials Australia
Spinal Cord Injury
1 trial -
Tenecteplase
Neuroscience Trials Australia
Ischemic Stroke
1 trial -
Tranexamic Acid
Neuroscience Trials Australia
Intracerebral Haemorrhage
1 trial
Frequently asked questions
How many clinical projects does Neuroscience Trials Australia have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.